W. Ben Deibler
Direktor/Vorstandsmitglied bei OcuCure Therapeutics, Inc.
Profil
W.
Ben Deibler is currently a Director at OcuCure Therapeutics, Inc. He previously worked as a Principal at Johnson & Johnson and as a Vice President-Business Development at Johnson & Johnson Vision Care, Inc. Deibler received an undergraduate degree from Drexel University and an MBA from Fairleigh Dickinson University.
Aktive Positionen von W. Ben Deibler
Unternehmen | Position | Beginn |
---|---|---|
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von W. Ben Deibler
Unternehmen | Position | Ende |
---|---|---|
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL. | Corporate Officer/Principal | - |
Ausbildung von W. Ben Deibler
Drexel University | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 2 |
---|---|
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Health Technology |
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL. | Electronic Technology |